Artificial Cells for Replacement of Metabolic Organ Functions

References

• Adamson J. G., Moore C. Hemolink™, an o‐‐Raffinose crosslinked hemoglobin‐‐based oxygen carrier. Blood Substitutes: Principles, Methods, Products and Clinical Trials, T. M.S. Chang. Karger, Basel 1998; Vol. 2: 62–79
   Google Scholar
• Aebischer P., Schluep M., Deglon N., Joseph J. M., Hirt L., Heyd B., Goddard M., Hammang J. P., Zurn A. D., Kato A. C., Regli F., Baetge E. E. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 1996; 2: 696–699
   PubMed Web of Science ®Google Scholar
• Bourget L., Chang T. M.S. Phenylalanine ammonia‐‐lyase immobilized in microcapsules for the depleture of phenylalanine in plasma in phenylketonuric rat model. Biochim. Biophys. Acta. 1986; 883: 432–438
   PubMed Web of Science ®Google Scholar
• Bruni S., Chang T. M.S. Hepatocytes immobilized by microencapsulation in artificial cells: effects on hyperbiliru‐‐binemia in gunn rats. J. Biomat. Artif. Cells Artif. Organs 1989; 17: 403–412
   PubMedGoogle Scholar
• Bunn H. F., Jandl J. H. The renal handling of hemoglobin. Trans. Assoc. Am. Physicians 1968; 81: 147
   PubMedGoogle Scholar
• Chang T. M.S. Semipermeable microcapsules. Science 1964; 146: 524–525
   PubMed Web of Science ®Google Scholar
• Chang T. M.S. Semipermeable aqueous microcapsules [[“artificial cells”]]: with emphasis on experiments in an extracorporeal shunt system. Trans. Am. Soc. Artif. Intern. Organs. 1966; 12: 13–19
   PubMedGoogle Scholar
• Chang T. M.S. The in vivo effects of semipermeable microcapsules containing L‐‐asparaginase on 6C3HED lymphosarcoma. Nature 1971; 229(528)117–118
   PubMed Web of Science ®Google Scholar
• Chang T. M.S. Stabilization of enzyme by microencapsulation with a concentrated protein solution or by crosslinking with glutaraldehyde. Biochem. Biophys. Res. Commun. 1971; 44: 1531–1533
   PubMed Web of Science ®Google Scholar
• Chang T. M.S. Artificial Cells. C.C., Thomas Publisher, Springfield 1972
   Google Scholar
• Chang T. M.S. Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure. Kidney Int. 1975; 7: S387–S392
   Web of Science ®Google Scholar
• Chang T. M.S. Artificial cells with emphasis on bioencapsulation in biotechnology. Biotechnol. Ann. Rev. 1995; 1: 267–295
   PubMedGoogle Scholar
• Chang T. M.S. Artificial Cells “Encyclopedia of Human Biology”2nd ed., R. Dulbecco. Academic Press, San Diego, CA 1997; 457–463
   Google Scholar
• Chang T. M.S. Live E. coli cells to treatment uremia: replies to letters to the editor. Nat. Med. 1997; 3: 2–3
   PubMedGoogle Scholar
• Chang T. M.S. Blood Substitutes: Principles, Methods, Products and Clinical Trials. Karger, Basel 1997; Vol. 1
   Google Scholar
• Chang T. M.S. Artificial blood: a prospective. Trends Biotechnol. 1999; 17: 61–67
   PubMed Web of Science ®Google Scholar
• Chang T. M.S. Is there a need for blood substitutes in the new millennium and what can we expect in the way of safety and efficacy. Artif. Cells Blood Substit. Immobil. Biotechnol. 2000; 28(1)i–vii, an international journal
   Google Scholar
• Chang T. M.S. Bioencapsulated hepatocytes for experimental liver support. J. Hepatol. 2001; 34: 148–149
   PubMed Web of Science ®Google Scholar
• Chang T. M.S. Oxygen carriers. Curr. Opin. Invest. Drugs 2002; 3(8)1187–1190
   PubMedGoogle Scholar
• Chang T. M.S., Poznansky M. J. Semipermeable microcapsules containing catalase for enzyme replacement in acatalsaemic mice. Nature 1968; 218(5138)242–245
   Web of Science ®Google Scholar
• Chang T. M.S., Prakash S. Therapeutic uses of microencapsulated genetically engineered cells. Mol. Med. Today 1998; 4: 221–227
   PubMedGoogle Scholar
• Chang T. M.S., Prakash S. Procedure for microencapsulationof enzymes, cells and genetically engineered microorganisms. Mol. Biotechnol. 2001; 17: 249–260
   PubMed Web of Science ®Google Scholar
• Chang T. M.S., Prakash S.. Microencapsulated Genetically Engineered Microorganisms for Clinical Application. U.S. Patent 6,217,859, April 17, 2001
   Google Scholar
• Chang T. M.S., Prakash S.. Microencapsulated Genetically Engineered Microorganisms for Clinical Application. Japanese Patent 3228941, September 7, 2001
   Google Scholar
• Chang T. M.S., Wong H.. A Novel Method for Cell Encapsulation in Artificial Cells. USA Patent No. 5,084,350, Issued Jan. 28, 1992
   Google Scholar
• Chang T. M.S., Yu W. P.. Biodegradable polymer membrane containing hemoglobin for blood substitutes. U.S.A. Patent 5670173, September 23, 1997
   Google Scholar
• Chang T. M.S., Yu W. P. Nanoencapsulation of hemoglobin and red blood cell enzymes based on nanotechnology and biodegradable polymer. Blood Substitutes: Principles, Methods, Products and Clinical Trials, T. M.S. Chang. Karger, Basel 1998; Vol. 2: 216–231
   Google Scholar
• Chang T. M.S., Yu B.. Composition for Inhibiting Tumour Growth and Methods Thereof. US Provisional Patent Application 60//364,581, March 18, 2002
   Google Scholar
• Chang T. M.S., MacIntosh F. C., Mason S. G. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharm. 1966; 44: 115–128
   PubMed Web of Science ®Google Scholar
• Chang T. M.S., Bourget L., Lister C. New theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme‐‐artificial cells, as in removing phenylalanine in phenylketonuria. Artif. Cells Blood Substit. Immobil. Biotechnol. 1995; 25: 1–23
   Google Scholar
• Chang T. M.S., Powanda D., Yu W. P. Biodegradable Polymeric Nanocapsules and Uses Thereof. PCT. 2002
   Google Scholar
• D'Agnillo F., Chang T. M.S.. Modified Hemoglobin Blood Substitute from Cross‐‐Linked Hemoglobin‐‐Superoxide Dismutase‐‐Catalase. US Patent 5,606,025, Feb. 1997
   Google Scholar
• D'Agnillo F., Chang T. M.S. Polyhemoglobin‐‐superoxide dismutase, catalase as a blood substitute with antioxidant properties. Nat. Biotechnol. 1998; 16(7)667–671
   PubMed Web of Science ®Google Scholar
• D'Agnillo F., Chang T. M.S. Absence of hemoprotein‐‐associated free radical events following oxidant challenge of crosslinked hemoglobin‐‐superoxide dismutase‐‐catalase. Free Radic. Biol. Med. 1998; 24(6)906–912
   PubMed Web of Science ®Google Scholar
• Dionne K. E., Cain B. M., Li R. H., Bell W. J., Doherty E. J., Rein D. H., Lysaght M. J., Gentile F. T. Transport characterization of membranes for immunoisolation. Biomaterials 1996; 17: 257–266
   PubMed Web of Science ®Google Scholar
• Djordjevich L., Miller I. F. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp. Hematol. 1980; 8: 584
   PubMed Web of Science ®Google Scholar
• Doherty D. H., Doyle M. P., Curry S. R., Vali R. J., Fattor T. J., Olson J. S., Lemon D. D. Rate of reaction with nitric oxide determines the hypertensive effect of cell‐‐free hemoglobin. Nat. Biotechnol. 1998; 16: 672–676
   PubMed Web of Science ®Google Scholar
• Dudziak R., Bonhard K. The development of hemoglobin preparations for various indications. Anesthesist 1980; 29: 181–187
   PubMed Web of Science ®Google Scholar
• Freytag J. W., Templeton D. Optro™ [[Recombinant human hemoglobin]]: a therapeutic for the delivery of oxygen and the restoration of blood volume in the treatment of acute blood loss in trauma and surgery. Red Cell Substitutes; Basic Principles and Clinical Application, A. S. Rudolph, R. Rabinovici, G. Z. Feuerstein. Marcel Dekker, Inc., New York 1997; 325–334
   Google Scholar
• Gould S. A., Moore F. A., et al. The first randomized tiral of human polymerized hemoglobin as a blood stubstitute in acute trauma and emergent surgery. J. Am. Coll. Surg. 1998; 187: 113–120
   PubMed Web of Science ®Google Scholar
• Gould S. A., Sehgal L. R., Sehgal H. L., DeWoskin R., Moss G. S. The clinical development of human polymerized hemoglobin. Blood Substitutes: Principles, Methods, Products and Clinical Trials, T. M.S. Chang. Karger, Basel 1998; Vol. 2: 12–28
   Google Scholar
• Hoffman S. J., Looker D. L., Roehrich J. M., et al. Expression of fully functional tetrameric human hemoglobin in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A., 87: 8521–8525
   PubMed Web of Science ®Google Scholar
• Bioartificial Organs A: Technology, Medicine and Material, D. Hunkeler, A. Prokop, A. D. Cherrington, R. Rajotte, M. Sefton. Ann. N.Y. Acad. Sci, 1999; Vol. 875, Acad. Sci, 831: 271–279
   Google Scholar
• Cell Encapsulation Technology and Therapy, W. M. Kulitreibez, P. P. Lauza, W. L. Cuicks. Burkhauser, Boston 1999
   Google Scholar
• Lim F., Sun A. M. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908–909
   PubMed Web of Science ®Google Scholar
• Liu Z., Chang T. M.S. Effects of bone marrow cells on hepatocytes: when co‐‐cultured or co‐‐encapsulated together. Artif. Cells Blood Substit. Immobil. Biotechnol. 2000; 28(4)365–374, an international journal
   PubMed Web of Science ®Google Scholar
• Liu Z. C., Chang T. M.S. Transplantation of co‐‐encapsulated hepatocytes and marrow stem cells into rats. Artif. Cells Blood Substit. Immobil. Biotechnol. 2002; 30: 99–112, an international journal
   PubMed Web of Science ®Google Scholar
• Liu J., Jia X., Zhang J., Xiang G., Hu W., Zhou Y. Study on a novel strategy to treatment of Phenylketonuria. Artif. Cells Blood Substit. Immobil. Biotechnol. 2002; 30: 243–258
   PubMed Web of Science ®Google Scholar
• Nelson D. J. Blood and HemAssist™ [[DCLHb]]: potentially a complementary therapeutic team. Blood Substitutes: Principles, Methods, Products and Clinical Trials, T. M.S. Chang. Karger, Basel 1998; Vol. 2: 39–57
   Google Scholar
• Orive G., Hernandez R. M., Gascon A. R., Calafiore R., Chang T. M.S., et al. Cell encapsulation: promise and progress. Nat. Med. 2003; 9: 104–107
   PubMed Web of Science ®Google Scholar
• Palmour R. M., Goodyer P., Reade T., Chang T. M.S. Microencapsulated xanthine oxidase as experimental therapy in Lesch‐‐Nyhan Disease. Lancet 1989; 2(8664)687–688
   PubMed Web of Science ®Google Scholar
• Pearce L. B., Gawryl M. S. Overview of preclinical and clinical efficacy of biopure's HBOCs. Blood Substitutes: Principles, Methods, Products and Clinical Trials, T. M.S. Chang. Karger, Basel 1998; Vol. 2: 82–98
   Google Scholar
• Philips W. T., Klpper R. W., Awasthi V. D., Rudolph A. S., Cliff R., Kwasiborski V. V., Goins B. A. Polyethylene glyco‐‐modified liposome‐‐encapsulated hemoglobin: a long circulating red cell substitute. J. Pharmacol. Exp. Ther. 1999; 288: 665–670
   PubMed Web of Science ®Google Scholar
• Powanda D., Chang T. M.S. Cross‐‐linked polyhemoglobin‐‐superoxide dismutase‐‐catalase supplies oxygen without causing blood brain barrier disruption or brain edema in a rat model of transient global brain ischemia‐‐reperfusion. Artif. Cells Blood Substit. Immobil. Biotechnol. 2002; 30: 25–42, an international journal
   Google Scholar
• Poznansky M. J., Chang T. M.S. Comparison of the enzyme kinetics and immunological properties of catalase immobi lized by microencapsulation and catalase in free solution for enzyme replacement. Biochim. Biophys. Acta. 1974; 334: 103–115
   Web of Science ®Google Scholar
• Prakash S., Chang T. M.S. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat. Med. 1996; 2(8)883–887
   PubMed Web of Science ®Google Scholar
• Prakash S., Chang T. M.S. Growth kinetics of genetically engineered E. coli dh 5 cells in artificial cell APA membrane microcapsules: preliminary report. Artif. Cells Blood Substit. Immobil. Biotechnol. 1999; 27(3)291–301, an international journal
   PubMed Web of Science ®Google Scholar
• Razack S., D'Agnillo F., Chang T. M.S. Effects of polyhemoglobin‐‐catalase‐‐superoxide dismutase on oxygen radicals in an ischemia‐‐reperfusion rat intestinal model. Artif. Cells Blood Substit. Immobil. Biotechnol. 1997; 25: 181–192
   PubMed Web of Science ®Google Scholar
• Red Blood Cell Substitutes, A. S. Rudolph, R. Rabinovici, G. Z. Feuerstein. Marcel Dekker, Inc., New York 1997
   Google Scholar
• Sarkissian C. N., Shao Z., Blain F., Peevers R., Su H., Heft R., Chang T. M.S., Scriver C. R. A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase. Proc. Natl. Acad. Sci. 1999; 96: 2339–2344
   PubMed Web of Science ®Google Scholar
• Blood Substitutes: Present and Future Perspectives, E. Tsuchida. Elservier, Amsterdam 1998
   Google Scholar
• Winchester J. F. Hemoperfusion. Replacement_of_Renal Function by Dialysis, J. F. Maher. Kluwer Academic, Boston 1988; 439–592
   Google Scholar
• Blood Substitutes: Industrial Opportunities and Medical Challenges, R. M. Winslow, K. D. Vandegriff, M. Intaglietta. Birkhauser, Boston 1997
   Google Scholar
• Wong H., Chang T. M.S. Bioartificial liver: implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int. J. Artif. Organs 1986; 9: 335–336
   PubMed Web of Science ®Google Scholar
• Wong H., Chang T. M.S. The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice. J. Biomat. Artif. Cells Artif. Organs 1988; 16: 731–740
   PubMedGoogle Scholar
• Wong H., Chang T. M.S. Microencapsulation of cells within alginate poly‐‐L‐‐lysine microcapsules prepared with standard single step drop technique: histologically identified membrane imperfections and the associated graft rejection. Biomater. Artif. Cells Immobil. Biotechnol. 1991; 19: 675–686
   PubMed Web of Science ®Google Scholar
• Wong H., Chang T. M.S. A novel two‐‐step procedure for immobilizing living cells in microcapsule for improving xenograft survival. Biomater. Artif. Cells Immobil. Biotechnol. 1991; 19: 687–698
   PubMed Web of Science ®Google Scholar
• Yu W. P., Chang T. M.S. Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization. Artif. Cells Blood Substit. Immobil. Biotechnol. 1996; 24: 169–184, an international journal
   PubMed Web of Science ®Google Scholar
• Yu B. L., Chang T. M.S. In‐‐vitro kinetics of encapsulated tyrosinase. Artif. Cells Blood Substit. Immobil. Biotechnol. 2002; 30: 533–546, an international journal
   PubMed Web of Science ®Google Scholar